Emerging Nanotechnologies in Immunology
-10%
portes grátis
Emerging Nanotechnologies in Immunology
The Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines
Shegokar, Ranjita; Souto, Eliana B.
Elsevier - Health Sciences Division
05/2018
290
Dura
Inglês
9780323400169
15 a 20 dias
770
Descrição não disponível.
1. Nanopharmaceutics in immunology: what's new in research? Ranjita Shegokar, Ana Rita Fernandes and Eliana Souto 2. Skin delivery of antimicrobial peptides Monika Schaefer-Korting and Jens Rolff 3. Skin penetration of nanoparticles Shohreh Nafisi and Howard I. Maibach 4. Regulatory and risk assessment perspective for Core-Multishell Nanocarriers: A novel excipient on its way towards marketing authorization Sam D. More, Margret More, Florian Paulus, Emanuel Fleige amd Marcin Libera 5. Anti-inflammatory drugs: Pharmaceutical Nanotechnology approach Andjelka B. Kovacevic, Sergio M.C.Silva and Slavomira Doktorovova 6. New strategies for the treatment of auto-immune diseases using nanotechnologies Amelia M. Silva, Joao R. Siopa, Carlos Martins-Gomes, Maria C. Teixeira, Dario J. Santos, Maria dos Anjos Pires and Tatiana Andreani 7. Nanopharmaceutics Applications in Inhaler Systems Aysu Yurdasiper, Mesut Arici and Mine Ozyazici 8. Immunomodulatory Effects of Curcumin in infectious and non-infectious diseases Ranjita Shegokar 9. Advances in Antibiotic Nanotherapy: Overcoming Antimicrobial Resistance Teixeira, M.C., Sanchez-Lopez, E., Espina, M., Calpena, A.C., Silva, A.M., Veiga, F.J., Garcia, M. L., Souto, E.B.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antibiotics; Anticancer peptides; Antimicrobial peptides (AMPs); Atopic dermatitis; Autoimmunity; Cancer; Cathelicidins; Core-multishell (CMS) nanocarriers; Curcumin; Cytochrome P450; DendroSol; Diabetes mellitus type I; Drug delivery; Drug delivery systems; Encapsulation; Excipient; Formulation; Glucocorticoids; Good manufacturing practice (GMP); HIV/AIDS; Human beta-defensins; Immune suppression; Immunology; Inflammation; Inhaled drug delivery devices; Lupus erythematosus; Malaria; Multidrug resistance; Multiple sclerosis; NLCs; NPs; NSAIDs; Nanoparticle toxicity; Nanoparticles; Nanotechnology; Powder inhalation; Psoriasis; Pulmonary medicine; Regulatory; Rheumatoid arthritis; Risk assessment; SLNs; Skin penetration; Tuberculosis; Wound healing
1. Nanopharmaceutics in immunology: what's new in research? Ranjita Shegokar, Ana Rita Fernandes and Eliana Souto 2. Skin delivery of antimicrobial peptides Monika Schaefer-Korting and Jens Rolff 3. Skin penetration of nanoparticles Shohreh Nafisi and Howard I. Maibach 4. Regulatory and risk assessment perspective for Core-Multishell Nanocarriers: A novel excipient on its way towards marketing authorization Sam D. More, Margret More, Florian Paulus, Emanuel Fleige amd Marcin Libera 5. Anti-inflammatory drugs: Pharmaceutical Nanotechnology approach Andjelka B. Kovacevic, Sergio M.C.Silva and Slavomira Doktorovova 6. New strategies for the treatment of auto-immune diseases using nanotechnologies Amelia M. Silva, Joao R. Siopa, Carlos Martins-Gomes, Maria C. Teixeira, Dario J. Santos, Maria dos Anjos Pires and Tatiana Andreani 7. Nanopharmaceutics Applications in Inhaler Systems Aysu Yurdasiper, Mesut Arici and Mine Ozyazici 8. Immunomodulatory Effects of Curcumin in infectious and non-infectious diseases Ranjita Shegokar 9. Advances in Antibiotic Nanotherapy: Overcoming Antimicrobial Resistance Teixeira, M.C., Sanchez-Lopez, E., Espina, M., Calpena, A.C., Silva, A.M., Veiga, F.J., Garcia, M. L., Souto, E.B.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antibiotics; Anticancer peptides; Antimicrobial peptides (AMPs); Atopic dermatitis; Autoimmunity; Cancer; Cathelicidins; Core-multishell (CMS) nanocarriers; Curcumin; Cytochrome P450; DendroSol; Diabetes mellitus type I; Drug delivery; Drug delivery systems; Encapsulation; Excipient; Formulation; Glucocorticoids; Good manufacturing practice (GMP); HIV/AIDS; Human beta-defensins; Immune suppression; Immunology; Inflammation; Inhaled drug delivery devices; Lupus erythematosus; Malaria; Multidrug resistance; Multiple sclerosis; NLCs; NPs; NSAIDs; Nanoparticle toxicity; Nanoparticles; Nanotechnology; Powder inhalation; Psoriasis; Pulmonary medicine; Regulatory; Rheumatoid arthritis; Risk assessment; SLNs; Skin penetration; Tuberculosis; Wound healing
